Peter D. Roselt

2.5k citations
74 papers · 2.0k · 1 hit paper · h-index 27

Impact in

Papers in

Peter D. Roselt

71 papers receiving 2.0k citations

Peter D. Roselt's Hit Papers

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial 2023 · 154 citations
1540+1+2Years since publication50100150

Peers

Peter D. Roselt
Comparison fields: 5 of 95
  • Radiology, Nuclear Medicine and Imaging 1.1k
  • Oncology 540
  • Pulmonary and Respiratory Medicine 472
  • Cancer Research 208
  • Pharmaceutical Science 56
Replace Frank Roesch with:
Frank Roesch Germany
Yasushi Arano Japan
Jason L.J. Dearling United States
Luigi Aloj Italy
Mark A. Green United States
Guiyang Hao United States
Veerle Kersemans United Kingdom
Karen E. Linder United States
Michael J. Welch United States
Matthias Friebe Germany
Peter D. Roselt relative to Frank Roesch Germany Frank Roesch's profile →
Citations per field
00.5×1.6×
Frank Roesch · 1×
Citations per year

Countries citing papers authored by Peter D. Roselt

Since Specialization
Citations

This map shows the geographic impact of Peter D. Roselt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Roselt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Roselt more than expected).

Fields of papers citing papers by Peter D. Roselt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Roselt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Roselt. The network helps show where Peter D. Roselt may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter D. Roselt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter D. Roselt Line = papers co-authored together Peter D. Roselt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Hit paper breakdown →
2023154
2 2018128
3
Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
200795
4 201693
5 201390
6 201389
7 201358
8 201358
9 201055
10 202055
11 201955
12 201554
13 201052
14 201149
15 200948
16 200546
17 201043
18 201940
19 200637
20 201537

About Peter D. Roselt

Peter D. Roselt is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Cancer Research, having authored 74 papers that have together received 2.0k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (36 papers), Medical Imaging Techniques and Applications (14 papers), Peptidase Inhibition and Analysis (11 papers), Chemical Synthesis and Analysis (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Prostate Cancer Treatment and Research (7 papers), Lung Cancer Research Studies (5 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Oncology (540 citations), Pulmonary and Respiratory Medicine (472 citations), Cancer Research (208 citations) and Pharmaceutical Science (56 citations). Peter D. Roselt has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Rodney John Hicks, Carleen M. Cullinane, Paul S. Donnelly, David Binns, Donna S. Dorow, Jonathan Michael White, Andrew G. Katsifis, Delphine Denoyer, Charmaine M. Jeffery and Brett M. Paterson. Their work appears in journals such as Journal of Nuclear Medicine, Bioconjugate Chemistry, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Medicinal Chemistry and EJNMMI Radiopharmacy and Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact